Related Experiment Video
Updated: Nov 4, 2025

11:44
Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
Published on: August 29, 2016
11.2K
Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function
Juan I Garaycoechea1, Gerry P Crossan, Frederic Langevin
1MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH, UK.
Nature
|August 28, 2012
Summary
Aging hematopoietic stem cells (HSCs) accumulate DNA damage due to reactive aldehydes. The Fanconi anemia DNA repair pathway and aldehyde detoxification protect HSCs, preventing bone marrow failure.
Area of Science:
- Hematology
- DNA Repair
- Aging Biology
Background:
- Hematopoietic stem cells (HSCs) are crucial for lifelong blood regeneration.
- HSC function declines with age, partly due to DNA damage accumulation.
- Factors causing DNA damage and protective mechanisms in HSCs are not fully understood.
Purpose of the Study:
- To investigate the role of aldehyde detoxification and Fanconi anemia DNA repair pathway in HSC protection.
- To understand the mechanisms underlying age-related bone marrow failure.
Main Methods:
- Utilized Aldh2 knockout (aldehyde catabolism) and Fancd2 knockout (Fanconi anemia pathway) mouse models.
- Analyzed DNA damage accumulation in hematopoietic stem and progenitor cells (HSPCs).
- Assessed aldehyde-oxidizing activity in HSPCs using Aldefluor stain.
Main Results:
- Aged Aldh2(-/-)Fancd2(-/-) mice developed aplastic anemia with accumulated DNA damage in HSPCs.
- HSPCs, but not mature blood precursors, require Aldh2 for protection against acetaldehyde toxicity.
- Aldehyde-oxidizing activity in HSPCs is Aldh2-dependent and correlates with protection.
- Combined deficiency led to a >600-fold reduction in the HSC pool.
Conclusions:
- Aldehyde-mediated genotoxicity, restricted to the HSPC pool, likely causes bone marrow failure in Fanconi anemia.
- Identified a link between endogenous reactive metabolites, DNA damage in HSCs, and protective mechanisms.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
3.6K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K
Mutagenicity and Carcinogenicity
1.6K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.6K

